Double maintains 2 strategies that include CLDX - Celldex Therapeutics, Inc.
Yahoo
Over the last 7 days, the United States market has experienced a 2.6% drop, yet it has shown resilience with a 24% rise over the past year and earnings projected to grow by 15% annually. In this dynamic environment, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer unique opportunities for investors seeking to capitalize on emerging growth prospects.
Yahoo
Key Insights Celldex Therapeutics' estimated fair value is US$33.97 based on 2 Stage Free Cash Flow to Equity Celldex...
Yahoo
HAMPTON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD is one of the most common chronic inflammatory skin diseases, with a lifetime prevalence of up to 20% of the US population and a substantial impact on quality of life1. Mast cells are strongly implicated in all facets of AD pathophysiology and the fu
Yahoo
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo
HAMPTON, N.J., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 1a study of CDX-622 in healthy volunteers. CDX-622 is a bispecific antibody that targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin (TSLP) and depleting mast cells via stem cell factor (SCF) starvation. “The introduction of our first bispecific candidat
Yahoo
HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences: Guggenheim Healthcare Innovation Conference on Tuesday, November 12th at 4:00 p.m. ET 7th Annual Evercore HealthCONx Conference on Tuesday, December 3rd at 4:15 p.m. ET Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex websi
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BNED | 0.01% | $332.96M | -88.33% | 0.00% |
MDT | 0.06% | $114.44B | +4.03% | 3.13% |
CQP | -0.07% | $29.82B | +17.59% | 5.19% |
DXCM | -0.07% | $34.26B | -30.67% | 0.00% |
EGO | 0.08% | $3.08B | +20.85% | 0.00% |
ASC | 0.08% | $482.85M | -27.74% | 9.33% |
HTHT | -0.10% | $9.99B | -5.57% | 0.00% |
GNK | -0.11% | $614.00M | -17.57% | 10.90% |
CNC | 0.12% | $32.88B | -11.46% | 0.00% |
FSM | -0.13% | $1.39B | +43.69% | 0.00% |
LUNR | -0.16% | $2.00B | +762.65% | 0.00% |
CMG | -0.17% | $78.43B | +24.49% | 0.00% |
HAS | -0.19% | $8.03B | +14.90% | 4.84% |
EDU | 0.19% | $7.64B | -41.74% | 0.00% |
CLX | -0.21% | $19.91B | +11.56% | 3.01% |
VSTS | 0.21% | $2.14B | -24.39% | 0.87% |
STKL | 0.25% | $867.36M | +21.61% | 0.00% |
DG | 0.27% | $15.69B | -46.32% | 3.30% |
RSG | -0.27% | $66.47B | +24.66% | 1.05% |
RPT | -0.27% | $130.36M | -46.05% | 9.82% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KRYS | 60.05% | $4.46B | +28.48% | 0.00% |
ITRI | 49.30% | $4.87B | +45.77% | 0.00% |
ALT | 47.58% | $502.14M | -23.92% | 0.00% |
MIST | 41.48% | $109.32M | +30.57% | 0.00% |
BEAM | 41.42% | $2.18B | +5.50% | 0.00% |
KYMR | 41.17% | $2.86B | +38.91% | 0.00% |
NTLA | 40.92% | $1.15B | -55.00% | 0.00% |
CRNX | 39.82% | $3.64B | +5.23% | 0.00% |
PRTA | 39.45% | $832.96M | -51.72% | 0.00% |
DMRC | 38.71% | $875.23M | +15.32% | 0.00% |
SDGR | 37.45% | $1.78B | -9.12% | 0.00% |
EDIT | 37.33% | $116.39M | -81.88% | 0.00% |
NRIX | 36.86% | $1.41B | +146.42% | 0.00% |
XPER | 36.41% | $407.95M | -20.39% | 0.00% |
ATXS | 36.07% | $426.08M | -23.35% | 0.00% |
BPMC | 36.03% | $7.35B | +41.55% | 0.00% |
PHR | 35.15% | $1.59B | +8.90% | 0.00% |
XNCR | 34.81% | $1.43B | +3.18% | 0.00% |
ZYME | 34.54% | $1.03B | +43.60% | 0.00% |
MARA | 34.53% | $6.77B | +22.62% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EW | -14.12% | $40.65B | -6.28% | 0.00% |
CBOE | -12.04% | $21.11B | +6.85% | 1.18% |
WM | -11.84% | $84.33B | +13.51% | 1.43% |
SEG | -11.65% | $336.69M | +2.90% | 0.00% |
STG | -8.25% | $36.34M | -25.99% | 0.00% |
K | -7.91% | $28.19B | +49.68% | 2.77% |
CCEC | -7.33% | $1.00B | +2.08% | 3.22% |
STNG | -7.32% | $2.54B | -30.59% | 3.34% |
IMNN | -6.91% | $13.88M | +70.98% | 0.00% |
MVO | -6.74% | $84.87M | -38.60% | 17.96% |
QD | -6.69% | $401.73M | +43.63% | 0.00% |
SBUX | -6.40% | $111.10B | +5.81% | 2.37% |
GFI | -6.34% | $14.45B | +18.49% | 2.33% |
TTE | -6.22% | $133.98B | -9.49% | 5.65% |
FRO | -6.19% | $3.75B | -22.60% | 11.62% |
ROIC | -6.05% | $2.25B | +23.76% | 3.44% |
PRT | -5.93% | $50.85M | -11.06% | 10.13% |
TEM | -5.92% | $8.63B | 0.00% | 0.00% |
IFF | -5.75% | $22.11B | +4.97% | 1.86% |
TXO | -5.49% | $792.08M | +2.27% | 12.21% |
Current Value
$24.471 Year Return
Current Value
$24.471 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -22.84% | $195.31M | 0.85% |
CTA | -18.34% | $569.44M | 0.76% |
TAIL | -15.20% | $64.78M | 0.59% |
TPMN | -11.27% | $34.23M | 0.65% |
UUP | -10.76% | $634.18M | 0.77% |
CPER | -8.58% | $153.88M | 0.97% |
USCI | -8.33% | $204.49M | 1.07% |
DBA | -7.65% | $828.49M | 0.93% |
USDU | -7.49% | $397.66M | 0.5% |
DBB | -7.26% | $111.87M | 0.77% |
MUST | -6.77% | $423.28M | 0.23% |
SHYD | -5.17% | $312.73M | 0.35% |
FTGC | -5.09% | $2.39B | 1.02% |
AGZD | -4.82% | $148.70M | 0.23% |
UNG | -4.53% | $664.75M | 1.06% |
XHLF | -4.33% | $955.89M | 0.03% |
BCI | -4.16% | $1.38B | 0.26% |
BCD | -4.01% | $251.64M | 0.3% |
MEAR | -3.71% | $771.37M | 0.25% |
BILZ | -3.49% | $631.56M | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CGMU | 0.02% | $2.75B | 0.27% |
EWH | -0.02% | $598.73M | 0.5% |
GXC | -0.05% | $402.79M | 0.59% |
MCHI | -0.08% | $5.01B | 0.59% |
HTAB | 0.10% | $453.69M | 0.39% |
PFFR | -0.33% | $101.37M | 0.45% |
PWZ | 0.36% | $710.13M | 0.28% |
SUB | -0.59% | $8.74B | 0.07% |
CLOI | 0.64% | $816.76M | 0.4% |
FLCH | 0.65% | $145.20M | 0.19% |
BSSX | -0.67% | $63.89M | 0.18% |
BOXX | 0.68% | $4.86B | 0.1949% |
RING | 0.70% | $963.54M | 0.39% |
BSMW | 0.77% | $91.99M | 0.18% |
IBMN | -0.81% | $474.02M | 0.18% |
PHDG | 1.00% | $116.12M | 0.39% |
SHV | 1.10% | $19.07B | 0.15% |
MUB | 1.19% | $40.41B | 0.05% |
FXI | 1.21% | $7.20B | 0.74% |
GCC | -1.28% | $140.48M | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 52.37% | $6.27B | 0.35% |
PBE | 47.39% | $254.98M | 0.58% |
GNOM | 45.94% | $69.64M | 0.5% |
PTH | 44.40% | $123.48M | 0.6% |
IBB | 43.94% | $6.39B | 0.45% |
ARKG | 42.99% | $1.21B | 0.75% |
IWC | 42.18% | $982.44M | 0.6% |
IWO | 39.75% | $13.09B | 0.24% |
VTWO | 39.23% | $12.78B | 0.1% |
IWM | 38.97% | $73.87B | 0.19% |
FBT | 38.40% | $1.20B | 0.56% |
KOMP | 37.34% | $2.20B | 0.2% |
ISCG | 37.26% | $668.38M | 0.06% |
GSSC | 37.26% | $546.06M | 0.2% |
IWN | 36.92% | $12.32B | 0.24% |
BBH | 36.73% | $399.71M | 0.35% |
PSC | 36.45% | $786.05M | 0.38% |
XPH | 36.30% | $167.55M | 0.35% |
IJT | 36.27% | $6.71B | 0.18% |
ESML | 36.07% | $1.95B | 0.17% |